https://www.fiercebiotech.com/biotech/cell-therapy-biotech-obsidian-leverages-galera-reverse-merger-go-public
Obsidian leverages Galera reverse merger to go public
Apr 14, 2026 - Galera Therapeutics has found a partner via a reverse merger with Obsidian Therapeutics that will take oncology-focused Obsidian public.
reverse mergerto goobsidiangalerapublic
https://www.biopharmadive.com/news/obsidian-galera-reverse-merger-private-placement-cell-therapy/817532/
Obsidian, Galera to advance cell therapy following reverse merger | BioPharma Dive
The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement expected to deliver $350 million in...
cell therapyreverse mergerobsidiangaleraadvance
https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-inc-goes-public-via-a-reverse-merger-into-cactus-ventures-inc-185572952.html
Actinium Pharmaceuticals, Inc. Goes Public via a Reverse Merger into Cactus Ventures, Inc.
/PRNewswire/ -- Actinium Pharmaceuticals, Inc. ("Actinium") announced today that it went public via a reverse merger into Cactus Ventures, Inc. (OTCBB:...